theophylline has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulsum, S | 1 |
| Sudheendra, HV | 1 |
| Pandian, R | 1 |
| Ravindra, DR | 1 |
| Siddappa, G | 1 |
| R, N | 1 |
| Chevour, P | 1 |
| Ramachandran, B | 1 |
| Sagar, M | 1 |
| Jayaprakash, A | 1 |
| Mehta, A | 1 |
| Kekatpure, V | 1 |
| Hedne, N | 1 |
| Kuriakose, MA | 1 |
| Suresh, A | 1 |
1 other study available for theophylline and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Carcinoma, Squamous | 2017 |